Paper
7 September 2023 Phospholipid bioconjugation: advancements and applications in prodrug development and metabolic labeling
Jin Qian
Author Affiliations +
Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 127890Z (2023) https://doi.org/10.1117/12.2692454
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom
Abstract
Phospholipids have garnered significant research interest in recent years, primarily due to their applications in drug delivery systems such as liposomes. Utilizing bioconjugation techniques, phospholipids can serve as prodrug platforms, equipping various potent drugs with more desirable moieties and properties. Additionally, phospholipids can be conjugated to fluorescent molecules, facilitating metabolic studies by enabling the tracking and visualization of these lipids. This review primarily focuses on the role of phospholipids in prodrug development and metabolic labeling. We explore the benefits associated with phospholipid bioconjugation, highlighting recent advances in the field and providing insights into its future potential for the design and optimization of future therapeutics.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jin Qian "Phospholipid bioconjugation: advancements and applications in prodrug development and metabolic labeling", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 127890Z (7 September 2023); https://doi.org/10.1117/12.2692454
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Analog electronics

Tumors

Cancer

Nanoparticles

Head

Mode conditioning cables

Resistance

Back to Top